Hemispherx's Two Drugs, Ampligen(R) and Alferon(R) Ranked Highly in Sensitivity Testing Against MERS/SARS Coronaviruses
August 04, 2014 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Aug. 4, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) announced today a peer-reviewed electronic publication entitled "Sensitivity of SARS/MERS CoV to Interferons and...
Project HOPE Prepares to Send Medicines and Supplies to Sierra Leone Battling Deadly Ebola Outbreak
July 31, 2014 14:17 ET
|
Project HOPE
MILLWOOD, VA., July 31, 2014 (GLOBE NEWSWIRE) -- Project HOPE, an international health education and humanitarian organization, has begun efforts to secure medicines and supplies for Sierra Leone as...